Frontlight ResearchEarly access
Trial site
Consorci Hospital General Universitari de València
- 4running trials
- 2closed trials
The trials here
What the 6 trials at this site are about, from their registry records.
- Conditions
- Atopic dermatitis (eczema)1 trial
- Colorectal cancer1 trial
- Fatty liver disease (MASLD/MASH)1 trial
- Liver and biliary tract cancer1 trial
- Liver cirrhosis1 trial
- Melanoma1 trial
- Primary biliary cholangitis1 trial
- Triple-negative breast cancer1 trial
- Phase
- Phase 33 trials
- Phase 22 trials
- Phase 1/21 trial
- Status
- Active, not recruiting3 trials
- Completed2 trials
- Recruiting1 trial
- Lead sponsor
- Almirall, S.A.1 trial
- Calliditas Therapeutics Suisse SA1 trial
- GBG Forschungs GmbH1 trial
- HepaRegeniX GmbH1 trial
- Iovance Biotherapeutics, Inc.1 trial
- and 1 more
Running trials
Recruiting
Safety of HRX215 in Patients After Minor and Major Liver Resection
Active, not recruiting
Active, not recruiting
Sacituzumab Govitecan in Primary HER2-negative Breast Cancer
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Colorectal cancer1 recruiting
- Liver and biliary tract cancer1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 12 Nov 2026